PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 88 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,771,401 | -39.9% | 1,617,300 | -17.0% | 0.68% | -30.8% |
| Q2 2023 | $27,919,704 | +90.9% | 1,949,700 | -4.8% | 0.98% | +100.6% |
| Q1 2023 | $14,627,004 | -31.4% | 2,048,600 | +7.8% | 0.49% | +5.2% |
| Q4 2022 | $21,318,000 | +0.9% | 1,900,000 | -0.4% | 0.46% | +7.4% |
| Q3 2022 | $21,127,000 | +30.4% | 1,906,800 | -0.7% | 0.43% | +15.6% |
| Q2 2022 | $16,203,000 | -38.8% | 1,919,800 | -1.3% | 0.37% | -32.5% |
| Q1 2022 | $26,485,000 | -29.0% | 1,946,000 | +2.6% | 0.55% | -30.3% |
| Q4 2021 | $37,294,000 | +636.2% | 1,896,000 | +1143.3% | 0.79% | +382.3% |
| Q4 2020 | $5,066,000 | – | 152,500 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
| Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
| Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
| GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
| RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
| StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
| Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
| Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |